Tech Transfer Seekers Should Leave Business To The Pros, Novartis Director Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Strong management in licensing agreements is as important as sustainable funding, Novartis Exec Director Fischette says.
You may also be interested in...
NCI-Funded Researchers Are Patenting At Surprisingly High Rate, Report Says
More than one in four National Cancer Institute-funded scientists start their own healthcare companies based on their own discoveries.
Forest Files Memantine/Donepezil Fixed Combination For Alzheimer’s
Commercialization of the fixed-dose combo buys lifecycle management for Forest and should support future drug development for partner Adamas, the originator of the technology behind the combination.
Alzheimer’s, BRAIN Initiative Highlighted In $30 Billion NIH Budget Proposal
President Obama’s proposed $56 billion Opportunity, Growth and Security Initiative would add nearly $1 billion to the NIH budget but it is funded by offsets that are likely nonstarters in Congress.